Alnylam Pharmaceuticals, Inc. (ALNY)

331.69 -1.16 (-0.35%) USD  |  NASDAQ  |  Feb 25, 10:06
More

Alnylam Pharmaceuticals Interest Paid Supplemental Data (Quarterly)

Interest Paid Supplemental Data (Quarterly) Chart

View Interest Paid Supplemental Data (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Interest Paid Supplemental Data (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years

View Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Interest Paid Supplemental Data (Quarterly) Benchmarks

View Interest Paid Supplemental Data (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Biogen, Inc. Upgrade
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade